MGI Tech Co., Ltd. (SHA:688114)

Market Cap	21.27B -29.0%
Revenue (ttm)	2.78B -7.7%
Net Income	-236.93M
EPS	-0.58
Shares Out	412.53M
PE Ratio	n/a
Forward PE	222.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,394,797
Average Volume	3,099,946
Open	52.55
Previous Close	52.55
Day's Range	51.57 - 53.54
52-Week Range	51.57 - 93.93
Beta	-0.03
RSI	25.06
Earnings Date	Apr 25, 2026

About MGI Tech

MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally. Its products include sequencers, such as genetic sequencers, sequencing reagents, library prep kits multiplex immunofluorescence reagent staining sets, and bioinformatics analysis; lab automation products comprising sample pretreatment products, sample preparation platforms, and integrated testing pl...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 2,604
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688114

Financial Performance

In 2025, MGI Tech's revenue was 2.78 billion, a decrease of -7.73% compared to the previous year's 3.01 billion. Losses were -236.93 million, -60.57% less than in 2024.